News

News items are kept on the IHE website for 6 months. If you require an older news item, please contact us at [email protected].

For media inquiries, please contact John Sproule, Senior Policy Director at  [email protected]

Economics in Lab Medicine webinar

IHE CEO, Dr. Chris McCabe provided a webinar presentation – “Demonstrating Value in Laboratory Medicine” on July 14th, 2021 as part of the international educational platform Labroots. Data and insights from laboratory tests help guide clinical decision-making, support policy changes, healthcare service planning and can have substantial influence on care pathways. The ability to link the value of laboratory medicine to downstream outcomes is critically important. This webinar explored well-established tools used for health economic evaluation, as well as key considerations when performing health economic evaluations of laboratory tests. The IHE received support from Abbott for the webinar. The archived webinar can be viewed at the following links: Labroots: https://www.labroots.com/ms/webinar/demonstrating-value-health-economics-laboratory-medicine…
Read More

IHE participates in National Academies workshop on pandemic’s impact on aviation

Dr. Kate Harback, IHE Associate Director of Economics will be participating in a National Academy of Sciences workshop – “Aviation After a Year of Pandemic – Economics, People and Technology”. The workshop will examine what the future aviation industry will look like after a year of COVID-19?  The virtual workshop will take place on June 28-30, 2021 from 12-4:30pm ET and focus on the long-term impacts of the pandemic on the aviation industry including economics, personnel, technology, and future steps. Dr. Harback’s panel will explore the  question: “How has the economics of the aviation industry been affected by the current pandemic and what should be done to mitigate these impacts and assure the long-term economic viability? “. Dr. Harback https://www.ihe.ca/about/staff-directory/kate-harback…
Read More

IHE collaborates on research project looking at Cannabis and Arthritis

The IHE is part of a research team funded by Alberta Innovates to investigate how widespread cannabis use is among arthritis patients. Self-medication and a lack of solid evidence to guide cannabis use for these purposes can lead to substantial harm. The research team will develop and validate a decision tool to help guide cannabis use to inform patients and health professionals. Information is available in the following Folio article:  Link: https://www.ualberta.ca/folio/2021/06/can-cannabis-help-with-arthritis-u-of-a-team-funded-by-alberta-innovates-to-develop-decision-tool-for-patients-and-health-care-providers.html   For further information John Sproule, Senior Policy Director, Institute of Health Economics, Ph: 780-862-1905  Email: [email protected] The Institute of Health Economics (IHE)…
Read More

Are financial incentives motivators for individuals not yet inoculated?

IHE Director of Economics Dr. Jeff Round participates in an interview with other colleagues for Global News about the pros and cons of using incentives to encourage members of the public to get vaccinated. Link:  https://globalnews.ca/news/7902049/alberta-covid-19-vaccine-incentives/ For further information: John Sproule, Senior Policy Director, Institute of Health Economics, Ph: 780-862-1905  Email: [email protected] The Institute of Health Economics (IHE) is an independent, not-for-profit research organization that conducts health economics and health services research, performs health technology assessments, and convenes health policy engagements for a wide variety of public and private health system stakeholders. Visit us at https://www.ihe.ca  to learn more.
Read More

Alberta project explores use of synthetic data as alternative to health data utilization

Merck Canada Joins Synthetic Data Project Edmonton, AB, May 11, 2021 – Health City and the Institute of Health Economics (IHE) are pleased to welcome Merck Canada as a new partner to an innovative Alberta collaboration aimed at exploring the potential uses for synthetic health data. Merck Canada will be joining existing partners Alberta Innovates and the University of Alberta, and will support the acceleration of research in the field of synthetic data use with the ultimate goal of helping improve health outcomes for Canadians.  Synthetic data accurately simulates patient-derived datasets and, although generated from real world data, is not linked to the individuals from whom the data were derived. Synthetic datasets can be shared freely among innovators and researchers without raising patient…
Read More